How much funding has Zymergen raised?

Zymergen has raised $928.1M in total funding, most recently a Series D round.

Who are Zymergen's investors?

Zymergen's investors include DCVC (Data Collab), SoftBank, Baillie Gifford, Goldman Sachs, Hanwha Asset Management, True Ventures.

Where is Zymergen headquartered?

Zymergen is headquartered in Emeryville, California, United States.

What industry is Zymergen in?

Zymergen operates in Advanced Materials, Artificial Intelligence, Biotech.

How many employees does Zymergen have?

Zymergen has 501-1000 employees.

Zymergen

Closed

Biology-based materials for a better world

Public · Emeryville, United States · Founded 2013 · $928.1M raised

Advanced Materials

Artificial Intelligence

Biotech

Headquarters: Emeryville, California
Employees: 501–1000
Founded: 2013
Business Model: B2B
Website: zymergen.com

Total Funding: $928.1M
Last Round: $300.0M Series DSep 2020
Rounds: 6
Type: Public

About

Zymergen was founded in 2013 in Emeryville, California as a biomanufacturing company using AI, machine learning, robotics, and synthetic biology to engineer microbes for the production of novel materials and chemicals. The company raised over $900 million before going public in April 2021. Ginkgo Bioworks acquired Zymergen in October 2022 for approximately $300 million, integrating its software, data science tools, and automation capabilities.

Summary

Zymergen is an Advanced Materials company based in Emeryville, United States, founded in 2013. It has raised $928.1M in total across 6 rounds, most recently a $300.0M Series D round in Sep 2020. Investors include DCVC (Data Collab), SoftBank and Baillie Gifford.

LinkedIn X (Twitter)